Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)

v3.22.4
Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Shares    
Beginning balance outstanding, shares (in shares) 150  
Granted, shares (in shares) 0  
Exercised, shares (in shares) (2)  
Forfeited, shares (in shares) 0  
Expired, shares (in shares) (1)  
Ending balance outstanding, shares (in shares) 147 150
Exercisable, shares (in shares) 72  
Weighted-average exercise price    
Weighted average exercise price, outstanding (in dollars per share) $ 82.16 $ 82.22
Granted, weighted-average exercise price (in dollars per share) 0  
Exercised, weighted-average exercise price (in dollars per share) 63.02  
Forfeited, weighted-average exercise price (in dollars per share) 0  
Expired, weighted-average exercise price (in dollars per share) 116.06  
Exercisable, weighted-average exercise price (in dollars per share) $ 90.63  
Weighted-average remaining contractual term    
Weighted-average remaining contractual term, outstanding (years) 1 year 3 months 18 days 2 years 3 months 18 days
Exercisable, weighted-average remaining contractual term (years) 1 year 1 month 6 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding $ 0 $ 3,596
Exercisable, aggregate intrinsic value $ 0